eNews Bulletin: Volume 23, Issue 12 - Download PDF
Methadose™ – What Is It?
Methadose 10mg/mL is a pre-mix Methadone oral solution for the treatment of opioid dependence. As Methadose is a pre-made, concentrated oral liquid solution, compounding is not required. This means that the total prescription cost of Methadose solution is comprised of two components:
Methadone, is a compound drug primarily used to treat opioid dependence and for the relief of chronic pain. As Methadone is only available in powder form, a pharmacist must prepare the prescription as a compound oral liquid solution. This means the total prescription cost of a Methadone compound is comprised of three components:
Methadose can result in a savings to your plan in two ways:
- The elimination of compounding fees for opioid dependence claims, and
- Due to Methadose being a concentrated product, by replacing Methadone compounds with Methadose for drug addiction, Methadone prescription expenditure can potentially be reduced by approximately 30%.
Will This Change Affect My Members at the Pharmacy Level?
We anticipate that there will be no impact to your members at point-of-sale.
Why The Change?
The Provincial Drug Plans of Ontario, British Columbia and Alberta, in an effort to reduce costs, have now excluded Methadone compound solution for the treatment of drug addiction and will only reimburse the cost of Methadose.
Effective November 1, 2014, In light of the Provincial Drug Plan changes, ClaimSecure will only reimburse Methadose 10mg/mL for the treatment of opioid dependence in these provinces. This means that Methadone compounds will no longer be considered eligible for opioid dependence; however, ClaimSecure will continue to reimburse for Methadone compound claims - for pain management and for patients who experience an adverse reaction to Methadose.
Should you have any questions about this policy, please contact your Client Service Associate at 1-888-479-7587.